115 related articles for article (PubMed ID: 1558637)
1. Reimbursement for home i.v. therapy.
Cieplak P
Ostomy Wound Manage; 1992 Mar; 38(2):73-5. PubMed ID: 1558637
[No Abstract] [Full Text] [Related]
2. Medicare covers home i.v. drug therapy.
Grimaldi PL
Nurs Manage; 1989 Dec; 20(12):14, 17. PubMed ID: 2687740
[No Abstract] [Full Text] [Related]
3. Medicare reimbursement for intravenous vancomycin at home.
Weiss PJ; Poirier TC
N Engl J Med; 1995 Apr; 332(15):1037. PubMed ID: 7885423
[No Abstract] [Full Text] [Related]
4. I.v. therapy: the legislative and regulatory arena.
Hughes C; Berke D
Caring; 1990 May; 9(5):4-7. PubMed ID: 10106790
[TBL] [Abstract][Full Text] [Related]
5. Unissued rules worry home care providers.
Lutz S
Mod Healthc; 1989 Sep; 19(35):34, 36. PubMed ID: 10303811
[No Abstract] [Full Text] [Related]
6. Hospitals poised to offer in-home i.v. therapy.
Robinson ML
Hospitals; 1989 Jul; 63(14):16, 20. PubMed ID: 2666297
[No Abstract] [Full Text] [Related]
7. Medicare program; payment for home intravenous drug therapy services--HCFA. Proposed rule.
Fed Regist; 1989 Nov; 54(215):46938-53. PubMed ID: 10303985
[TBL] [Abstract][Full Text] [Related]
8. Home intravenous drug therapy under Medicare.
Leader S
Pride Inst J Long Term Home Health Care; 1989; 8(3):8-14. PubMed ID: 10303820
[No Abstract] [Full Text] [Related]
9. Home iv therapy benefit of the Catastrophic Coverage Act: it's impact on home care providers.
Marren J; Rodgers B; Dishon M
Pride Inst J Long Term Home Health Care; 1989; 8(3):15-8. PubMed ID: 10303818
[No Abstract] [Full Text] [Related]
10. Alternatives to financing home health care.
Kass DI
Bus Health; 1987 May; 4(7):16-20. PubMed ID: 10301483
[No Abstract] [Full Text] [Related]
11. Medicare program; conditions of participation for home intravenous drug therapy providers--HCFA. Proposed rule.
Fed Regist; 1989 Sep; 54(172):37220-38. PubMed ID: 10303828
[TBL] [Abstract][Full Text] [Related]
12. PPS for home health services?
Grimaldi PL
Nurs Manage; 1985 Dec; 16(12):16-8. PubMed ID: 3906457
[No Abstract] [Full Text] [Related]
13. Preparing for loss of waiver.
Engelbrecht L
Home Health J; 1986 May; 7(5):15. PubMed ID: 10302375
[No Abstract] [Full Text] [Related]
14. Medicare program; coverage of home intravenous drug therapy services--HCFA. Proposed rule.
Fed Regist; 1989 Sep; 54(172):37422-38. PubMed ID: 10303831
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in federal reimbursement for home health-care services and products.
Curtiss FR
Am J Hosp Pharm; 1988 Aug; 45(8):1682-90. PubMed ID: 3064589
[TBL] [Abstract][Full Text] [Related]
16. Reimbursement dilemma regarding home health-care products and services.
Curtiss FR
Am J Hosp Pharm; 1984 Aug; 41(8):1548-57. PubMed ID: 6433706
[TBL] [Abstract][Full Text] [Related]
17. State associations weigh in on impact of IPS.
McGinn K
Caring; 1998 Feb; 17(2):44-9. PubMed ID: 10178036
[No Abstract] [Full Text] [Related]
18. Medicare/Medicaid reimbursement for home care services.
Westbrook NH
Hosp Food Nutr Focus; 1995 May; 11(9):6-7. PubMed ID: 10142568
[No Abstract] [Full Text] [Related]
19. Nuts and bolts of home care social work: Part 1--Reimbursement.
de St Aubin M
Continuum; 1997; 17(1):13-7. PubMed ID: 10165617
[No Abstract] [Full Text] [Related]
20. Health Care Financing Administration--Medicare and Medicaid programs; schedule of limits on home health agency costs per visit. Proposed notice.
Fed Regist; 1980 Feb; 45(33):10450-6. PubMed ID: 10297686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
